What question did this study set out to answer?

This research aims to understand how Kupffer cells regulate T cell responses through the VSIG4-CD5 interaction and its implications for tumor evasion.

May 2, 2026

Kupffer cell calibration of T cell responses via VSIG4-CD5 interaction promotes tumor evasion.

Puntos clave

This research aims to understand how Kupffer cells regulate T cell responses through the VSIG4-CD5 interaction and its implications for tumor evasion.
Blockade of VSIG4-CD5 interaction using a nanoantibody in mice.
Assessment of tumor metaplasia and T cell activation.
Evaluation of the synergy between VSIG4 blockade and anti-PD-L1 therapy.
Blockade of VSIG4-CD5 interaction increased T cell activation and reduced tumor outgrowth.
Achieved synergistic efficacy against liver metastases with anti-PD-L1 therapy, indicating improved immune response.

Resumen

T cells by rescuing them from activation-induced cell death. This bidirectional regulation favors the outgrowth of poorly immunogenic metastatic tumor clones and fosters an immune landscape that is unfavorable to T cells as metastatic liver cancer progresses. We also show that blockade of VSIG4-CD5 interaction using a nanoantibody to VSIG4 sensitizes liver metastases to anti-PD-L1 therapy, achieving synergistic efficacy in mice. These findings provide mechanistic insights into cancer immunoediting during liver metastasis and a possible approach for treating immunologically cold tumors.

Preguntar a la IA

Me gusta

Guardar